We identified 413 genes significantly associated with HCP5 through the LinkedOmics database and found that they were mainly associated with immunity in AML patients, including regulation of T-cell activation, lymphocyte-mediated immunity, and Th17 cell differentiation (Supplementary Figure S1). The gene discussed is HCP5; the disease is acute myeloid leukemia.